» Articles » PMID: 16208014

Outbreaks in Distinct Regions Due to a Single Klebsiella Pneumoniae Clone Carrying a Bla VIM-1 Metallo-{beta}-lactamase Gene

Overview
Specialty Microbiology
Date 2005 Oct 7
PMID 16208014
Citations 26
Authors
Affiliations
Soon will be listed here.
Abstract

From December 2004 to March 2005, 27 Klebsiella pneumoniae clinical isolates that were positive by the imipenem-EDTA double-disk synergy test and that exhibited a single macro-restriction pattern were recovered in two distinct Greek hospitals. The isolates carried a transferable bla(VIM-1) metallo-beta-lactamase gene in a class 1 integron. Reverse transcriptase PCR showed that the gene was similarly expressed in low- and high-level carbapenem-resistant isolates, indicating the existence of additional resistance mechanisms. The clonal spread of VIM-1-producing K. pneumoniae strains in distinct regions where up to now bla(VIM-2) and bla(VIM-4) alleles were common is worrisome.

Citing Articles

A Multispecies Cluster of VIM-1 Carbapenemase-Producing Linked by a Novel, Highly Conjugative, and Broad-Host-Range IncA Plasmid Forebodes the Reemergence of VIM-1.

Arcari G, Di Lella F, Bibbolino G, Mengoni F, Beccaccioli M, Antonelli G Antimicrob Agents Chemother. 2020; 64(4).

PMID: 32015041 PMC: 7179263. DOI: 10.1128/AAC.02435-19.


First Italian outbreak of VIM-producing in an adult polyvalent intensive care unit, August-October 2018: A case report and literature review.

Iovene M, Pota V, Galdiero M, Corvino G, Di Lella F, Stelitano D World J Clin Cases. 2019; 7(21):3535-3548.

PMID: 31750335 PMC: 6854422. DOI: 10.12998/wjcc.v7.i21.3535.


Detection of New Delhi Metallo-Beta-Lactamase-1 (NDM-1) in carbapenem- resistant Klebsiella pneumoniae isolated from a university hospital in Iran.

Fazeli H, Norouzi-Barough M, Ahadi A, Shokri D, Solgi H Hippokratia. 2016; 19(3):205-9.

PMID: 27418777 PMC: 4938465.


Emergence of Carbapenem-Resistant Klebsiella pneumoniae: Progressive Spread and Four-Year Period of Observation in a Cardiac Surgery Division.

Lombardi F, Gaia P, Valaperta R, Cornetta M, Tejada M, di Girolamo L Biomed Res Int. 2015; 2015:871947.

PMID: 26064962 PMC: 4434196. DOI: 10.1155/2015/871947.


The spread of carbapenemase-producing bacteria in Africa: a systematic review.

Manenzhe R, Zar H, Nicol M, Kaba M J Antimicrob Chemother. 2014; 70(1):23-40.

PMID: 25261423 PMC: 5975721. DOI: 10.1093/jac/dku356.


References
1.
Tsakris A, Pournaras S, Woodford N, Palepou M, Babini G, Douboyas J . Outbreak of infections caused by Pseudomonas aeruginosa producing VIM-1 carbapenemase in Greece. J Clin Microbiol. 2000; 38(3):1290-2. PMC: 88610. DOI: 10.1128/JCM.38.3.1290-1292.2000. View

2.
Poirel L, Naas T, Nicolas D, Collet L, Bellais S, Cavallo J . Characterization of VIM-2, a carbapenem-hydrolyzing metallo-beta-lactamase and its plasmid- and integron-borne gene from a Pseudomonas aeruginosa clinical isolate in France. Antimicrob Agents Chemother. 2000; 44(4):891-7. PMC: 89788. DOI: 10.1128/AAC.44.4.891-897.2000. View

3.
Mavroidi A, Tsakris A, Tzelepi E, Pournaras S, Loukova V, Tzouvelekis L . Carbapenem-hydrolysing VIM-2 metallo- beta-lactamase in Pseudomonas aeruginosa from Greece. J Antimicrob Chemother. 2000; 46(6):1041-2. DOI: 10.1093/jac/46.6.1041. View

4.
Yan J, Hsueh P, Ko W, Luh K, Tsai S, Wu H . Metallo-beta-lactamases in clinical Pseudomonas isolates in Taiwan and identification of VIM-3, a novel variant of the VIM-2 enzyme. Antimicrob Agents Chemother. 2001; 45(8):2224-8. PMC: 90635. DOI: 10.1128/AAC.45.8.2224-2228.2001. View

5.
Livermore D . The impact of carbapenemases on antimicrobial development and therapy. Curr Opin Investig Drugs. 2002; 3(2):218-24. View